NITTAGELANitta Gelatin India Limited
Chemicals · Specialty Chemicals · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Nitta Gelatin India Limited engages in the manufacture and sale of gelatin, ossein, dicalcium phosphate (DCP), and collagen peptides in India and internationally. It offers gelatin for pharmaceutical and edible applications; wellnex collagen peptides for collagen peptide absorption, diabetes management, bones and joints, and beauty products under the Gelixer CollagenPep brand name; and DCP for use in poultry feed. The company provides chitosan for food, pharmaceutical, textile, agriculture, water treatment, and cosmetics industries, as well as ossein for agriculture and industrial applications. It also exports its products. The company was formerly known as Kerala Chemicals & Proteins Limited and changed its name to Nitta Gelatin India Limited in 2008. Nitta Gelatin India Limited was incorporated in 1975 and is based in Kochi, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
The picture
- • Profit growth: 31.3% YoY
- • ROE: 19.0%
- • ROCE: 23.9%
- • MACD: bullish
- • Price vs EMA21: above
- • Bollinger position: 69% of band
- • EMA Crossover signal (setup quality 52%)
Bull case
- • Profit growth: 31.3% YoY
- • ROE: 19.0%
- • ROCE: 23.9%
- • MACD: bullish
Bear case
- • Revenue growth: -0.3% YoY
- • Dividend yield: 0.46%
- • Price vs SMA50: below
- • Supertrend: bearish
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • Revenue growth: -0.3% YoY
- • Dividend yield: 0.46%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹65.19). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.